Creative Planning’s Teva Pharmaceuticals TEVA Stock Holding History

Creative Planning’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$2K	–	4902
2016 Q4	$2K	Buy	+1,000	New	+$39.9K	﹤0.01%	4304
2016 Q3	–	Sell	-1,000	Closed	-$3K	–	4727
2016 Q2	$3K	Buy	+1,000	New	+$53.2K	﹤0.01%	3912
2015 Q4	–	Sell	-300	Closed	-$1K	–	4574
2015 Q3	$1K	Buy	+300	New	+$19.5K	﹤0.01%	4147
2014 Q4	–	Sell	-2,000	Closed	-$12K	–	4341
2014 Q3	$12K	Buy	+2,000	New	+$106K	﹤0.01%	2849

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Creative Planning's TEVA Position: Q1 2026 in Review

Creative Planning increased its Teva Pharmaceuticals (TEVA) stake by 3.3% in Q1 2026, buying an estimated $66.7K and bringing the position to 64,908 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Creative Planning first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.57M in Q3 2017. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Creative Planning held 64,908 shares of Teva Pharmaceuticals worth $1.96M as of Q1 2026.
Creative Planning bought 2,072 Teva Pharmaceuticals shares in Q1 2026, an estimated $66.7K.
Teva Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1901 holding.
Creative Planning first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Creative Planning's Teva Pharmaceuticals position peaked at $4.57M in Q3 2017.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.